Trial Profile
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck (Amended Version 20-March-2009) [SUBSTUDY OF 700024018]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer; Hypopharyngeal cancer; Laryngeal cancer; Oropharyngeal cancer; Squamous cell cancer
- Focus Pharmacokinetics
- Sponsors Amgen
- 21 Mar 2014 New trial record